EAE: imperfect but useful models of multiple sclerosis
- PMID: 21251877
- DOI: 10.1016/j.molmed.2010.11.006
EAE: imperfect but useful models of multiple sclerosis
Abstract
The high failure rate of immunotherapies in multiple sclerosis (MS) clinical trials demonstrates problems in translating new treatment concepts from animal models to the patient. One main reason for this 'immunotherapy gap' is the usage of immunologically immature, microbiologically clean and genetically homogeneous rodent strains. Another reason is the artificial nature of the experimental autoimmune encephalomyelitis model, which favors CD4+ T cell driven autoimmune mechanisms, whereas CD8+ T cells are prevalent in MS lesions. In this paper, we discuss preclinical models in humanized rodents and non-human primates that are genetically closer to MS. We also discuss models that best reproduce specific aspects of MS pathology and how these can potentially improve preclinical selection of promising therapies from the discovery pipeline.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Multiple sclerosis: human model for EAE?Eur J Immunol. 2009 Aug;39(8):2036-9. doi: 10.1002/eji.200939545. Eur J Immunol. 2009. PMID: 19672899
-
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.Crit Rev Clin Lab Sci. 1995;32(2):121-82. doi: 10.3109/10408369509084683. Crit Rev Clin Lab Sci. 1995. PMID: 7598789 Review.
-
Pathogenic mechanisms and experimental models of multiple sclerosis.Autoimmunity. 2010 Nov;43(7):504-13. doi: 10.3109/08916931003674733. Autoimmunity. 2010. PMID: 20380590 Review.
-
[Multiple sclerosis and experimental autoimmune encephalomyelitis].Rev Prat. 1994 Jan 1;44(1):69-74. Rev Prat. 1994. PMID: 8178062 French.
-
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.Ann Anat. 2010 Aug 20;192(4):179-93. doi: 10.1016/j.aanat.2010.06.006. Epub 2010 Jul 15. Ann Anat. 2010. PMID: 20692821 Review.
Cited by
-
Nanomaterials for antigen-specific immune tolerance therapy.Drug Deliv Transl Res. 2023 Jul;13(7):1859-1881. doi: 10.1007/s13346-022-01233-3. Epub 2022 Sep 12. Drug Deliv Transl Res. 2023. PMID: 36094655 Review.
-
Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.Front Immunol. 2021 Feb 19;12:620963. doi: 10.3389/fimmu.2021.620963. eCollection 2021. Front Immunol. 2021. PMID: 33679764 Free PMC article. Review.
-
The Cynomolgus Macaque MHC Polymorphism in Experimental Medicine.Cells. 2019 Aug 26;8(9):978. doi: 10.3390/cells8090978. Cells. 2019. PMID: 31455025 Free PMC article. Review.
-
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Front Immunol. 2017 May 8;8:529. doi: 10.3389/fimmu.2017.00529. eCollection 2017. Front Immunol. 2017. PMID: 28533781 Free PMC article. Review.
-
An essential role of virus-infected B cells in the marmoset experimental autoimmune encephalomyelitis model.Mult Scler J Exp Transl Clin. 2017 Jan 1;3(1):2055217317690184. doi: 10.1177/2055217317690184. eCollection 2017 Jan-Mar. Mult Scler J Exp Transl Clin. 2017. PMID: 28607749 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous